Dose-Ranging Study of LQ036 Single-Domain Antibody Nebulization Solution in Poorly Controlled Asthma
Clinical trial NCT07589439 · RECRUITING
Trial details
- NCT number
- NCT07589439
- Sponsor
- Shanghai Novamab Biopharmaceuticals Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-30
- Primary completion
- 2027-09-01
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.